Tumor marker response to SARS‐CoV‐2 infection among patients with cancer

Tumor marker response to SARS‐CoV‐2 infection among patients with cancer

Abstract Background Inflammatory responses from benign conditions can cause non‐cancer‐related elevations in tumor markers. The severe acute respiratory coronavirus 2 (SARS‐CoV‐2) induces a distinct viral inflammatory response, resulting in coronavirus disease 2019 (COVID‐19). Clinical data suggest...

Full description

Bibliographic Details
Main Authors: Alexander H. Gunn, Carolyn Tashie, Steven Wolf, Jesse D. Troy, Yousuf Zafar
Format: Article
Language:English
Published: Wiley 2022-07-01
Series:Cancer Medicine
Subjects:
cancer management
clinical management
clinical observations
COVID‐19
tumor markers
viral infection
Online Access:https://doi.org/10.1002/cam4.4646

Internet

https://doi.org/10.1002/cam4.4646

Similar Items